InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Hindman Andrew A., Chief Financial Officer. Insider active across 1 companies, notably Theravance Biopharma, Inc.. Cumulatively, 10 filings have been published. The latest transaction was filed on 20 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations10 total
€27,8003,365 shares@ €8.26170.0033% mcap3.9% of flow
Ordinary Shares
SEC:0001415889-22-005631:0·
€219,59425,973 shares@ €8.45470.026% mcap30.7% of flow
Ordinary Shares
SEC:0001415889-22-001699:0·
0340,000 shares0
Ordinary Shares
SEC:0001179110-21-010638·
0340,000 shares0
Ordinary Shares
SEC:0001179110-21-010638:0·
€9,9281,350 shares@ €7.35370.0012% mcap4.2% of flow
Ordinary Shares
SEC:0001415889-21-005466·
€9,9281,350 shares@ €7.35370.0012% mcap1.4% of flow
Ordinary Shares
SEC:0001415889-21-005466:0·
€210,13817,464 shares@ €12.03260.025% mcap89.9% of flow
Ordinary Shares
SEC:0001179110-21-008394·
€210,13817,464 shares@ €12.03260.025% mcap29.4% of flow
Ordinary Shares
SEC:0001179110-21-008394:0·
€13,715942 shares@ €14.55990.0016% mcap5.9% of flow
Ordinary Shares
SEC:0001179110-21-005842·
€13,715942 shares@ €14.55990.0016% mcap1.9% of flow
Ordinary Shares
SEC:0001179110-21-005842:0·
10 of 10 declarations
About Hindman Andrew A.
Andrew A. Hindman is Senior Vice President and Chief Financial Officer at Theravance Biopharma, Inc. He is responsible for the financial management of the company, overseeing accounting and financial operations.
